File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: P17 induces chemotaxis and differentiation of monocytes via MRGPRX2-mediated mast cell–line activation

TitleP17 induces chemotaxis and differentiation of monocytes via MRGPRX2-mediated mast cell–line activation
Authors
KeywordsMast cell activation
Innate immunity
Immune modulation
MRGPRX2
Mast cells
Monocytes
Human-monocyte–derived macrophages (h-MDMs)
Monocyte recruitment
Chemotaxis
Cytokine release
Issue Date2022
PublisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/jaci
Citation
Journal of Allergy and Clinical Immunology, 2022, v. 149 n. 1, p. 275-291 How to Cite?
AbstractBackground: P17, a peptide isolated from Tetramorium bicarinatum ant venom, is known to induce an alternative phenotype of human monocyte–derived macrophages via activation of an unknown G protein–coupled receptor (GPCR). Objective: We sought to investigate the mechanism of action and the immunomodulatory effects of P17 mediated through MRGPRX2 (Mas-related G protein–coupled receptor X2). Methods: To identify the GPCR for P17, we screened 314 GPCRs. Upon identification of MRGPRX2, a battery of in silico, in vitro, ex vivo, and in vivo assays along with the receptor mutation studies were performed. In particular, to investigate the immunomodulatory actions, we used β-hexosaminidase release assay, cytokine releases, quantification of mRNA expression, cell migration and differentiation assays, immunohistochemical labeling, hematoxylin and eosin, and immunofluorescence staining. Results: P17 activated MRGPRX2 in a dose-dependent manner in β-arrestin recruitment assay. In LAD2 cells, P17 induced calcium and β-hexosaminidase release. Quercetin- and short hairpin RNA–mediated knockdown of MRGPRX2 reduced P17-evoked β-hexosaminidase release. In silico and in vitro mutagenesis studies showed that residue Lys8 of P17 formed a cation-π interaction with the Phe172 of MRGPRX2 and [Ala8]P17 lost its activity partially. P17 activated LAD2 cells to recruit THP-1 and human monocytes in Transwell migration assay, whereas MRGPRX2-impaired LAD2 cells cannot. In addition, P17-treated LAD2 cells stimulated differentiation of THP-1 and human monocytes, as indicated by the enhanced expression of macrophage markers cluster of differentiation 11b and TNF-α by quantitative RT-PCR. Immunohistochemical and immunofluorescent staining suggested monocyte recruitment in mice ears injected with P17. Conclusions: Our data provide novel structural information regarding the interaction of P17 with MRGPRX2 and intracellular pathways for its immunomodulatory action.
Persistent Identifierhttp://hdl.handle.net/10722/304103
ISSN
2023 Impact Factor: 11.4
2023 SCImago Journal Rankings: 3.701
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorDuraisamy, K-
dc.contributor.authorSingh, K-
dc.contributor.authorKumar, M-
dc.contributor.authorLefranc, B-
dc.contributor.authorBonnafé, E-
dc.contributor.authorTreilhou, M-
dc.contributor.authorLeprince, J-
dc.contributor.authorChow, BKC-
dc.date.accessioned2021-09-23T08:55:16Z-
dc.date.available2021-09-23T08:55:16Z-
dc.date.issued2022-
dc.identifier.citationJournal of Allergy and Clinical Immunology, 2022, v. 149 n. 1, p. 275-291-
dc.identifier.issn0091-6749-
dc.identifier.urihttp://hdl.handle.net/10722/304103-
dc.description.abstractBackground: P17, a peptide isolated from Tetramorium bicarinatum ant venom, is known to induce an alternative phenotype of human monocyte–derived macrophages via activation of an unknown G protein–coupled receptor (GPCR). Objective: We sought to investigate the mechanism of action and the immunomodulatory effects of P17 mediated through MRGPRX2 (Mas-related G protein–coupled receptor X2). Methods: To identify the GPCR for P17, we screened 314 GPCRs. Upon identification of MRGPRX2, a battery of in silico, in vitro, ex vivo, and in vivo assays along with the receptor mutation studies were performed. In particular, to investigate the immunomodulatory actions, we used β-hexosaminidase release assay, cytokine releases, quantification of mRNA expression, cell migration and differentiation assays, immunohistochemical labeling, hematoxylin and eosin, and immunofluorescence staining. Results: P17 activated MRGPRX2 in a dose-dependent manner in β-arrestin recruitment assay. In LAD2 cells, P17 induced calcium and β-hexosaminidase release. Quercetin- and short hairpin RNA–mediated knockdown of MRGPRX2 reduced P17-evoked β-hexosaminidase release. In silico and in vitro mutagenesis studies showed that residue Lys8 of P17 formed a cation-π interaction with the Phe172 of MRGPRX2 and [Ala8]P17 lost its activity partially. P17 activated LAD2 cells to recruit THP-1 and human monocytes in Transwell migration assay, whereas MRGPRX2-impaired LAD2 cells cannot. In addition, P17-treated LAD2 cells stimulated differentiation of THP-1 and human monocytes, as indicated by the enhanced expression of macrophage markers cluster of differentiation 11b and TNF-α by quantitative RT-PCR. Immunohistochemical and immunofluorescent staining suggested monocyte recruitment in mice ears injected with P17. Conclusions: Our data provide novel structural information regarding the interaction of P17 with MRGPRX2 and intracellular pathways for its immunomodulatory action.-
dc.languageeng-
dc.publisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/jaci-
dc.relation.ispartofJournal of Allergy and Clinical Immunology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectMast cell activation-
dc.subjectInnate immunity-
dc.subjectImmune modulation-
dc.subjectMRGPRX2-
dc.subjectMast cells-
dc.subjectMonocytes-
dc.subjectHuman-monocyte–derived macrophages (h-MDMs)-
dc.subjectMonocyte recruitment-
dc.subjectChemotaxis-
dc.subjectCytokine release-
dc.titleP17 induces chemotaxis and differentiation of monocytes via MRGPRX2-mediated mast cell–line activation-
dc.typeArticle-
dc.identifier.emailChow, BKC: bkcc@hku.hk-
dc.identifier.authorityChow, BKC=rp00681-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.jaci.2021.04.040-
dc.identifier.pmid34111449-
dc.identifier.scopuseid_2-s2.0-85108797498-
dc.identifier.hkuros325635-
dc.identifier.volume149-
dc.identifier.issue1-
dc.identifier.spage275-
dc.identifier.epage291-
dc.identifier.isiWOS:000741453800009-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats